EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Exploring the impression of TRIM25 gene expression on COVID-19 severity and SARS-CoV-2 viral replication

Rezvan Tavakoli, Pooneh Rahimi, Abolfazl Fateh, Mojtaba Hamidi-Fard, Sana Eaybpoosh, Golnaz Bahramali, Seyed Amir Sadeghi, Delaram Doroud, Mohammadreza Aghasadeghi

Journal of Infection and Public Health · 2024

DOI: 10.1016/j.jiph.2024.102489 ↗

At a glance

Journal article in Journal of Infection and Public Health, 2024. Written by Rezvan Tavakoli and 8 co-authors. Institution: Department of Hepatitis and AIDS, Pasteur Institute of Iran, Tehran, Iran. Major MEDLINE topics: COVID-19, Tripartite Motif Proteins, Virus Replication, SARS-CoV-2. Cited 4 times so far (Crossref); 34 references. The full text is freely available (open access, CC BY 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

BACKGROUND: There are numerous human genes associated with viral infections, and their identification in specific populations can provide suitable therapeutic targets for modulating the host immune system response and better understanding the viral pathogenic mechanisms. Many antiviral signaling pathways, including Type I interferon and NF-κB, are regulated by TRIM proteins. Therefore, the identification of TRIM proteins involved in COVID-19 infection can play a significant role in understanding the innate immune response to this virus. METHODS: In this study, the expression of TRIM25 gene was evaluated in a blood sample of 330 patients admitted to the hospital (142 patients with severe disease and 188 patients with mild disease) as well as in 160 healthy individuals. The relationship between its expression and the severity of COVID-19 disease was assessed and compared among the study groups by quantitative Real-time PCR technique. The statistical analysis of the results demonstrated a significant reduction in the expression of TRIM25 in the group of patients with severe infection compared to those with mild infection. Furthermore, the impact of increased expression of TRIM25 gene in HEK-293 T cell culture was investigated on the replication of attenuated SARS-CoV-2 virus. RESULTS: The results of Real-time PCR, Western blot for the viral nucleocapsid gene of virus, and CCID50 test indicated a decrease in virus replication in these cells. The findings of this research indicated that the reduced expression of the TRIM25 gene was associated with increased disease severity of COVID-19 in individuals. Additionally, the results suggested the overexpression of TRIM25 gene can impress the replication of attenuated SARS-CoV-2 and the induction of beta-interferon. CONCLUSION: TRIM25 plays a critical role in controlling viral replication through its direct interaction with the virus and its involvement in inducing interferon during the early stages of infection. This makes TRIM25 a promising target for potential therapeutic interventions.

Subjects

MeSH terms (MEDLINE)

COVID-19Tripartite Motif ProteinsVirus ReplicationSARS-CoV-2Ubiquitin-Protein LigasesTranscription FactorsSeverity of Illness IndexHumansMaleFemaleMiddle AgedAdultHEK293 CellsImmunity, InnateGene ExpressionAged

Author keywords

COVID-19Innate immunityInterferonSARS-CoV-2 virusTRIM25

Substances

Tripartite Motif ProteinsTRIM25 protein, humanUbiquitin-Protein LigasesTranscription Factors

Authors and institutions

  • Department of Hepatitis and AIDS, Pasteur Institute of Iran, Tehran, Iran.
  • Department of Mycobacteriology and Pulmonary Research, Pasteur Institute of Iran, Tehran, Iran; Microbiology Research Center (MRC), Pasteur Institute of Iran, Tehran, Iran.
  • Department of Epidemiology and Biostatistics, Research Centre for Emerging and Reemerging Infectious Diseases, Pasteur Institute of Iran, Tehran, Iran.
  • Department of Production, Research and Production Complex, Pasteur Institute of Iran, Tehran, Iran.
  • Department of Hepatitis and AIDS, Pasteur Institute of Iran, Tehran, Iran. Electronic address: mr_sadeqi@yahoo.com.

Cite

APA

Tavakoli, R., Rahimi, P., Fateh, A., Hamidi-Fard, M., Eaybpoosh, S., Bahramali, G., Sadeghi, S. A., Doroud, D., & Aghasadeghi, M. (2024). Exploring the impression of TRIM25 gene expression on COVID-19 severity and SARS-CoV-2 viral replication. Journal of Infection and Public Health. https://doi.org/10.1016/j.jiph.2024.102489

Vancouver

Tavakoli R, Rahimi P, Fateh A, Hamidi-Fard M, Eaybpoosh S, Bahramali G, et al. Exploring the impression of TRIM25 gene expression on COVID-19 severity and SARS-CoV-2 viral replication. Journal of Infection and Public Health. 2024. doi:10.1016/j.jiph.2024.102489

BibTeX
@article{Tavakoli2024,
  author = {Tavakoli, Rezvan and Rahimi, Pooneh and Fateh, Abolfazl and Hamidi-Fard, Mojtaba and Eaybpoosh, Sana and Bahramali, Golnaz and Sadeghi, Seyed Amir and Doroud, Delaram and Aghasadeghi, Mohammadreza},
  title = {Exploring the impression of TRIM25 gene expression on COVID-19 severity and SARS-CoV-2 viral replication},
  journal = {Journal of Infection and Public Health},
  year = {2024},
  doi = {10.1016/j.jiph.2024.102489}
}
Start for free →